This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 08/22/2023
Location: Virtual
Subject: Items of Mutual Interest with Cancer Centers
FDA Participant/Group: COURTNEY BUCHANAN; ANDREW ZACHER; MICHELLE ADAMS;
Non FDA Participant/Group: Industry, academia, and government

Event Date: 08/22/2023
Location: Virtual
Subject: Alliance for a Stronger FDA: FDA Priorities and Resource Needs
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry and media

Event Date: 08/23/2023
Location: Virtual
Subject: FDA Human Foods Program
FDA Participant/Group: LAURA CARROLL; COURTNEY BUCHANAN;
Non FDA Participant/Group: Several stakeholders interested in the FDA Human Foods Program

Event Date: 08/23/2023
Location: Virtual
Subject: Stimulant Therapeutics
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several stakeholders within the Attention-Deficit/Hyperactivity Disorder (ADHD) professional societies

Event Date: 08/23/2023
Location: Virtual
Subject: FDA Human Foods Program
FDA Participant/Group: LAURA CARROLL;
Non FDA Participant/Group: Steve Troxler (Agriculture and Consumer Services for North Carolina); Ted McKinney (National Association of State Departments of Agriculture); Doug Miyamoto (Department of Agriculture Wyoming); Natalie Krout (California Department of Food and Agriculture);

Event Date: 08/23/2023
Location: Virtual
Subject: FDA Human Foods Program
FDA Participant/Group: JULIA TIERNEY; LAURA CARROLL;
Non FDA Participant/Group: Scott Gottlieb (New Enterprise Associates); Andrew Von Eschenbach (Samaritan Health); Jane Henney (University of Cincinnati Academic Health Center); David Kessler (University of California, San Francisco);

Event Date: 08/25/2023
Location: Halifax, Nova Scotia
Subject: 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; Town Hall: Global Regulatory Forum on Real-World Evidence
FDA Participant/Group: DONNA RIVERA; DANICA MARINAC; SEMA HASHEMI;
Non FDA Participant/Group: Industry, government, academia, and media

Event Date: 08/25/2023
Location: Halifax, Nova Scotia
Subject: Recent Organizational Updates
FDA Participant/Group: SEMA HASHEMI;
Non FDA Participant/Group: Kelly Robinson, Pamela Aung-Thin, Stephanie Millius (Health Canada);

Event Date: 08/25/2023
Location: Halifax, Nova Scotia
Subject: Follow-up with Regulators on Real-World Evidence
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Andrej Segec, Catherine Cohet, Daniel Morales LEaver, Patrice Verpillat (European Medicines Agency); Kelly Robinson, Melissa Kampman, Pamela Aung-Thin, Rania Mouchantaf, Stephanie Millius (Health Canada); Katherine Donegan (Medicines and Healthcare Products Regulatory Agencey, United Kingdom); Michal Hirsch Vexberg (Ministry of Health, Israel); Yoshiaki Uyama (Pharmaceuticals and Medical Devices Agency Japan);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 08/25/2023
Location: Virtual
Subject: Training Workshops on Organisation for Economic Co-operation and Development (OECD) Illicit Trade
FDA Participant/Group: N/A
Non FDA Participant/Group: Richard Wilder (Wilder Consulting);

Official Name: Carol Cave, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 08/21/2023
Location: Virtual
Subject: Heart Valve Collaboratory
FDA Participant/Group: N/A
Non FDA Participant/Group: Michael Mack (Baylor Scott & White Health); Martin Leon (Columbia University Medical Center);

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 08/24/2023
Location: Guayaquil, Ecuador
Subject: Subsecretariat of Quality and Safety (SCI) Sixth Anniversary - Signing Ceremony Between: DHHS / FDA and the Republic of Ecuador Ministry of Aquaculture and Fisheries "Safety of Imported Shrimp"
FDA Participant/Group: GONZALO IBANEZ; BRUCE ROSS; MICHELLE RODRIGUEZ; JULIE MOSS; STEVEN BLOODGOOD;
Non FDA Participant/Group: Diana Poveda (Agriculture and Fisheries of Ecuador); Andres Ahrens (Aquaculture and Fisheries); Alicia Gallardo; Catya Martinez (World Organization for Animal Health); Daniel Legarda (Ministry of Foreign Trade);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 08/25/2023
Location: Bloomfield, CO
Subject: National Association of Tobacco Outlets (NATO) Smoker Friendly Conference and Tobacco Festival; Keynote Remarks: Update from FDA's Center for Tobacco Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from National Association of Tobacco Outlets (NATO) and conference attendees

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event